Biotec Pharmacon is a scientific-based industrial company that are developing, producing and marketing immune modulating beta-glucans and cold adapted enzymes, including special formulated products derived from these ingredients. The Company operates in two business areas managed by two separate operating units.

investors-building

The shares of Biotec Pharmacon ASA are listed on the Oslo Stock Exchange. The listing took place on 4 November 2005. The ticker symbol for Biotec Pharmacon is BIOTEC.

Share registrar
DNB Bank ASA
Postboks 1600 Sentrum | NO-0021 Oslo | Norway
For <strong>Investor Relations</strong> inquiries, please contact our CFO
Børge Sørvoll,
P.O. Box 6463,
NO-9294 Tromsø
borge.sorvoll@biotec.no